A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells.

Patel JR, Thangavelu P, Terrell RM, Israel B, Sarkar AB, Davidson AM, Zhang K, Khupse R, Tilghman SL. A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells. Biomolecules. 2022 03 31; 12(4).

View in: PubMed

subject areas

Apoptosis
Cell Cycle Proteins
Cell Line, Tumor
Cell Proliferation
Humans
Proto-Oncogene Proteins

authors with profiles

Syreeta Tilghman

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support